Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Satellos Bioscience Inc T.MSCL

Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and... see more

TSX:MSCL - Post Discussion

View:
Post by Drambuey on Jun 14, 2022 7:15pm

Down again

Down .02 on volume guess we don't need your update Frankie boy!  Waste of time and money Frankie boy hope you got lucky and shipfaced, least us shareholders could do for you. Lol
Comment by Itistoo on Jun 16, 2022 6:36pm
and again..investors just wanting out at this point.. kicking myself for not exiting when we had that last bump to 1.20. It really seems like satellos has nothing going on other than hopes and dreams. They are out of money and a nice juicy dilution is imminent to further decimate the sp.
Comment by sovy888 on Jun 21, 2022 8:40pm
you're absolutely right... this looks more and more like a big time loser
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities